Proposed NSAID package insert labeling.

The United States Food and Drug Administration (FDA) has proposed new label warnings for all nonsteroidal anti-inflammatory drugs (NSAIDs) to warn about potential cardiovascular and other toxicities associated with these medications. The proposed label requirements are presented.